BRAX logo

Braxia Scientific Stock Price

Symbol: CNSX:BRAXMarket Cap: CA$1.4mCategory: Healthcare

BRAX Share Price Performance

BRAX Community Fair Values

    Recent BRAX News & Updates

    No updates

    Braxia Scientific Corp. Key Details

    CA$2.2m

    Revenue

    CA$1.9m

    Cost of Revenue

    CA$324.1k

    Gross Profit

    CA$10.0m

    Other Expenses

    -CA$9.6m

    Earnings

    Last Reported Earnings
    Dec 31, 2023
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -0.034
    Gross Margin
    14.67%
    Net Profit Margin
    -436.37%
    Debt/Equity Ratio
    -29.6%

    Braxia Scientific Corp. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About BRAX

    Founded
    n/a
    Employees
    n/a
    CEO
    WebsiteView website
    braxiascientific.com

    Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and development and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products from its IP development platform. The company is headquartered in Toronto, Ontario.

    Canadian Market Performance

    • 7 Days: 0.7%
    • 3 Months: 10.9%
    • 1 Year: 17.6%
    • Year to Date: 10.6%
    The Healthcare sector gained 4.2% while the market remained flat over the last week. Meanwhile, the market is actually up 18% over the past year. Looking forward, earnings are forecast to grow by 12% annually. Market details ›
    Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
    Continue reading